76 related articles for article (PubMed ID: 38183048)
1. A pH-Sensitive Nanoparticle as Reactive Oxygen Species Amplifier to Regulate Tumor Microenvironment and Potentiate Tumor Radiotherapy.
Jiang X; Jiang X; Wu D; Xie W; Liu X; Zheng J
Int J Nanomedicine; 2024; 19():709-725. PubMed ID: 38283195
[TBL] [Abstract][Full Text] [Related]
2. Enhancing cell pyroptosis with biomimetic nanoparticles for melanoma chemo-immunotherapy.
Sun S; He Y; Xu J; Leng S; Liu Y; Wan H; Yan L; Xu Y
J Control Release; 2024 Mar; 367():470-485. PubMed ID: 38290565
[TBL] [Abstract][Full Text] [Related]
3. Dual-Epigenetically Relieving the MYC-Correlated Immunosuppression via an Advanced Nano-Radiosensitizer Potentiates Cancer Immuno-Radiotherapy.
Wang G; Yan J; Tian H; Li B; Yu X; Feng Y; Li W; Zhou S; Dai Y
Adv Mater; 2024 May; 36(19):e2312588. PubMed ID: 38316447
[TBL] [Abstract][Full Text] [Related]
4. Radioresponsive Delivery of Toll-like Receptor 7/8 Agonist for Tumor Radioimmunotherapy Enabled by Core-Cross-Linked Diselenide Nanoparticles.
Wu Y; Qin J; Gu Y; Zhao G; Xu P; Lin S; Cheng X; Zhang LW; Wang Y; Wang Y
ACS Nano; 2024 Jan; 18(4):2800-2814. PubMed ID: 38227969
[TBL] [Abstract][Full Text] [Related]
5. A Biomathematical Model of Tumor Response to Radioimmunotherapy With αPDL1 and αCTLA4.
Gonzalez-Crespo I; Gomez-Caamano A; Pouso OL; Fenwick JD; Pardo-Montero J
IEEE/ACM Trans Comput Biol Bioinform; 2023; 20(2):808-821. PubMed ID: 35544486
[TBL] [Abstract][Full Text] [Related]
6. An Oral Nanomedicine Elicits
Zu M; Ma Y; Zhang J; Sun J; Shahbazi MA; Pan G; Reis RL; Kundu SC; Liu J; Xiao B
ACS Nano; 2024 Jan; 18(4):3651-3668. PubMed ID: 38241481
[TBL] [Abstract][Full Text] [Related]
7. Overcoming neutrophil-induced immunosuppression in postoperative cancer therapy: Combined sialic acid-modified liposomes with scaffold-based vaccines.
Li C; Wang L; Zhang K; Wang Z; Li Z; Li Z; Chen L
Asian J Pharm Sci; 2024 Apr; 19(2):100906. PubMed ID: 38595333
[TBL] [Abstract][Full Text] [Related]
8. Novel antigens for targeted radioimmunotherapy in hepatocellular carcinoma.
Pourhamzeh M; Asadian S; Mirzaei H; Minaei A; Shahriari E; Shpichka A; Es HA; Timashev P; Hassan M; Vosough M
Mol Cell Biochem; 2023 Jan; 478(1):23-37. PubMed ID: 35708866
[TBL] [Abstract][Full Text] [Related]
9. Immune mechanisms mediating abscopal effects in radioimmunotherapy.
Rodriguez-Ruiz ME; Rodriguez I; Leaman O; López-Campos F; Montero A; Conde AJ; Aristu JJ; Lara P; Calvo FM; Melero I
Pharmacol Ther; 2019 Apr; 196():195-203. PubMed ID: 30529041
[TBL] [Abstract][Full Text] [Related]
10. Assembling Au
Zhang R; Jia M; Lv H; Li M; Ding G; Cheng G; Li J
J Nanobiotechnology; 2024 Jan; 22(1):20. PubMed ID: 38183048
[TBL] [Abstract][Full Text] [Related]
11. Alleviating the hypoxic tumor microenvironment with MnO
Pi F; Deng X; Xue Q; Zheng L; Liu H; Yang F; Chen T
J Nanobiotechnology; 2023 Mar; 21(1):90. PubMed ID: 36922836
[TBL] [Abstract][Full Text] [Related]
12. Photothermal-Activatable Fe
Ge R; Liu C; Zhang X; Wang W; Li B; Liu J; Liu Y; Sun H; Zhang D; Hou Y; Zhang H; Yang B
ACS Appl Mater Interfaces; 2018 Jun; 10(24):20342-20355. PubMed ID: 29878757
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy.
Chen Q; Chen J; Yang Z; Xu J; Xu L; Liang C; Han X; Liu Z
Adv Mater; 2019 Mar; 31(10):e1802228. PubMed ID: 30663118
[TBL] [Abstract][Full Text] [Related]
14. Atomically Precise Gold-Levonorgestrel Nanocluster as a Radiosensitizer for Enhanced Cancer Therapy.
Jia TT; Yang G; Mo SJ; Wang ZY; Li BJ; Ma W; Guo YX; Chen X; Zhao X; Liu JQ; Zang SQ
ACS Nano; 2019 Jul; 13(7):8320-8328. PubMed ID: 31241895
[TBL] [Abstract][Full Text] [Related]
15. Hybrid Membrane Nanovaccines Combined with Immune Checkpoint Blockade to Enhance Cancer Immunotherapy.
Zhao P; Xu Y; Ji W; Li L; Qiu L; Zhou S; Qian Z; Zhang H
Int J Nanomedicine; 2022; 17():73-89. PubMed ID: 35027827
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
